Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
Journal
Oncotarget
Journal Volume
8
Journal Issue
52
Pages
90430-90443
Date Issued
2017
Publisher
Impact Journals LLC
Type
journal article